๐ฐ Eric Lander News
Page 15 - Eric Lander News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eric Lander. Real-time updates on events, politics, business and more.
May 4, 2022
This is the second request urging the Biden administration to put forth a nominee for the Office of Science and Technology Policy.
May 3, 2022
Sen. Roger Wicker, R-Miss., called on the Biden Administration to immediately nominate the next Director of the Office of Science and Technology Policy (OSTP) after the resignation of President Biden's top science adviser and former OSTP director Dr. Eric Lander.
May 3, 2022
FDA and its advisers will likely need to consider yearly updates to the Covid-19 vaccine.
May 2, 2022
Anna Greka has become a champion for patients with rare diseases, blurring the sharp lines that often lie between the lab and the real world.
April 29, 2022
The OSTP is without a leader in the wake of a scandal. Itโs time for the White House to think about getting a new kind of director.
April 20, 2022
Have you ever watched any of the "Terminator" movies with Arnold Schwarzenegger? If you have, you will be familiar with the evil villain "Skynet," which is a fictional artificial, neural network-based, conscious group-mind and artificial general...
April 20, 2022
Test your understanding of the living world with this simple question.ย What kind of biomolecule is found in all ...
April 15, 2022
The race to build autonomous weapons will have as much impact on military affairs in the twenty-first century as aircraft did on land and naval warfare in the twentieth century.
April 13, 2022
In this quarterly news roundup on issues of scientific integrity, Liz Borkowski describes the CDC's potentially misleading new COVID-19 monitoring, bullying at the White House Office of Science and Technology Policy, and the state of federal scientific integrity policies.
April 8, 2022
Biotechnology intrinsically blurs boundaries between science and commerce, market and state, the global and the national, and even personal privacy and collective interest. Progress depends more heavily in biotech than in other high-tech industries on knowledge networks and transnational collaboration, especially those that connect the United States and China.